Skip to main content
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ARTL ISIN · US04301G7060 US Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2020-10-19 Major Shareholding Noti…
Country US United States of America
Listing US ARTL

About ARTELO BIOSCIENCES, INC.

https://artelobio.com/

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics. The company's scientific approach is centered on modifying lipid-signaling pathways, particularly by modulating the endocannabinoid system. Its primary therapeutic focus is on developing improved treatments for patients with cancer and other serious diseases. Artelo is advancing a diverse portfolio of drug candidates through its development pipeline to address unmet medical needs.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2020
Major Shareholding Notification
2020-10-19 English
ARTELO BIOSCIENCES, INC.
Major Shareholding Notification
2020-10-15 English
SCHEDULE 13G
Major Shareholding Notification
2020-10-15 English
ARTELO BIOSCIENCES, INC.
Major Shareholding Notification
2020-10-15 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content details the entry into a material definitive agreement related to a public offering of units consisting of common stock and warrants, including underwriting agreements, overallotment options, and closing of the offering. It also includes press releases about the pricing and closing of the offering. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is primarily an announcement of a capital raising event and related agreements. Therefore, it fits the category of Capital/Financing Update (CAP).
2020-10-14 English
424B4 - PROSPECTUS
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus filed pursuant to Rule 424(b)(4) for a public offering of units consisting of common stock and warrants. It includes extensive information about the offering, underwriting, risk factors, management discussion and analysis, business overview, and financial statements. The presence of terms like 'prospectus', 'offering', 'underwriting', and detailed securities description indicates this is a capital raising document. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is not an annual or quarterly report, nor is it a regulatory filing or announcement. It is a primary offering document for new securities issuance.
2020-10-13 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.